---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-006341"
form_type: "8-K"
ticker: "GLUE"
cik: "0001826457"
company_name: "Monte Rosa Therapeutics, Inc."
filed_at: "2026-01-07T23:59:59+00:00"
generated_at: "2026-05-16T11:24:09.132618+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Monte Rosa Therapeutics terminates ATM stock sale program; no further sales until new prospectus filed

## Summary
- Effective January 7, 2026, company terminated the ATM prospectus under its shelf registration.
- No further sales of common stock under the Sales Agreement unless new prospectus filed.
- As of termination date, 2,955,082 shares sold for net proceeds of $24.2 million.
- Sales Agreement with Jefferies remains in effect but no sales currently authorized.
- Reason for termination not disclosed.

## SEC filing metadata
- accession: 0001193125-26-006341
- form_type: 8-K
- ticker: GLUE
- cik: 0001826457
- company_name: Monte Rosa Therapeutics, Inc.
- filed_at: 2026-01-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/0001193125-26-006341-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826457/000119312526006341/glue-20260107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-006341
- JSON: https://secwatch.observer/filing/0001193125-26-006341.json
- Plain text: https://secwatch.observer/filing/0001193125-26-006341.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.